Toshiki Tomita

Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma

Yorihisa Imanishi, Masato Fujii, Yutaka Tokumaru et al. · Human Pathology · 2000 · 85 citations

Medicine, Oncology, Pathology +14

Surgical results of an endoscopic endonasal approach for clival chordomas

Katsuya Saito, Masahiro Toda, Toshiki Tomita et al. · Acta Neurochirurgica · 2012 · 66 citations

Medicine, Neurosurgery, Surgery +10

Overexpression of SIP1 and Downregulation of E-cadherin Predict Delayed Neck Metastasis in Stage I/II Oral Tongue Squamous Cell Carcinoma After Partial Glossectomy

Koji Sakamoto, Yorihisa Imanishi, Toshiki Tomita et al. · Annals of Surgical Oncology · 2011 · 61 citations

Medicine, Cancer Biology, Oncology +14

Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma

Ryoichi Fujii, Yorihisa Imanishi, Katsushi Shibata et al. · Journal of Experimental & Clinical Cancer Research · 2014 · 59 citations · Full text

Medicine, Oncology, Pharmacology +16

Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells

Toshiki Tomita, Masato Fujii, Yutaka Tokumaru et al. · Cancer Letters · 2000 · 45 citations

Medicine, Immunology, Oncology +12